Ven Bio Partners LLC Portfolio Holdings

Ven Bio Partners LLC

  • $177 Million
  • Q2 2024

Ven Bio Partners LLC has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $177 Million distributed in 6 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Pharvaris N.V. with a value of $80.6M, Alx Oncology Holdings Inc with a value of $58.5M, Harmony Biosciences Holdings, Inc. with a value of $31.2M, Elevation Oncology, Inc. with a value of $6.57M, and Acelyrin Inc with a value of $0.

Examining the 13F form we can see an decrease of $78.9M in the current position value, from $256M to 177M.

Ven Bio Partners LLC is based out at San Francisco, CA

Below you can find more details about Ven Bio Partners LLC portfolio as well as his latest detailed transactions.

Portfolio value $177 Million
Healthcare: $177 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$13.7M
$6.57 Million 3.71% of portfolio
2,434,255
Q2 2024 Reduced 9.71%

Summary

  • Portfolio
  • No. of Stocks 6
  • Current Value $177 Million
  • Prior Value $256 Million
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Ven Bio Partners LLC Portfolio

Follow Ven Bio Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ven Bio Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ven Bio Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email